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Abstract. An analysis of indices of nonspecific resis-
tance of the organism in patients with eczema, depending 
on the nature of the clinical course of dermatosis has been 
carried out. We established unidirectional changes in indic-
es of phagocytosis and complement levels in patients with 
eczema of different clinical course with more substantial 
reduction in phagocytic activity of phagocytic blood cells in 
patients with microbial eczema compared with true eczema 
without probable differences in indices depending on the 
area of phagocytosis skin and the duration of the dermatosis 
course. 
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Introduction. Eczema is common chronic de-
rmatosis, belonging to the group of  allergic diseases 
of the skin, which occupies from 20 % to 40 % in the 
structure of dermatological pathology in Ukraine [1, 
2]. In recent years there has been a tendency to more 
severe clinical course of eczema with significant skin 
lesions and formation of the torpidity to the means of 
basic therapy with a tendency to chronic pathologic 
process and the development of complications, leadi-
ng to a decrease or loss of long-term patient capacity, 
deteriorating quality of life and social activities . 
This defines an important medical and social signifi-
cance of eczema and justifies the relevance of the 
research and study of pathogenetic factors of derma-
tosis in order to improve its treatment and prevention 
[2, 10, 12].  
According to current research, the pathogenesis 
of eczema is complex and multifactorial. It is known 
that the development of eczema exogenous and en-
dogenous factors, such as compromised immune and 
endocrine regulation disorders,  the digestive system 
disorders, changes in the circulation, chronic foci of 
focal infection etc. are significant [1, 11, 13].  
It was established that changes in systemic im-
munity [4, 5], including secondary immunod-
eficiency of various origins that lead to violations of 
cellular and humoral immunity, as well as changes in 
the indices of nonspecific resistance of the organism 
play an important role in the development and of 
skin diseases and their becoming chronic [7, 9], but 
their role in the pathogenesis of eczema can not be 
considered completely clear as data on indice of ph-
agocytic activity of phagocytic blood cells and the 
complement system in patients with eczema are ofte-
n ambiguous and contradictory. In this regard, the 
determination of the features of nonspecific resista-
nce indices of the organism in patients with eczema 
with different clinical course in order to clarify the 
pathogenetic factors of dermatosis is important.  
Objective. To identify and analyze the perform-
ance of nonspecific resistance of the organism in 
patients with eczema, depending on the clinical cour-
se of dermatosis. 
Material and methods. We have examined 92 
patients with eczema, including 49 men and 43 
women, aged from 18 to 79.  
The criteria for inclusion in the study were: 
presence of clinical manifestations of eczema; 
patient’s age – 18 years old or more; absence of 
chronic physical illness or its relapse at the time of 
examination.  
According to clinical criteria [3], the majority 
(63 people – 68,5 %) of patients were diagnosed with 
microbial eczema, including varicose, and 
paratraumatic and mycotic, the remaining 29 
(31,5 %) patients had real (true) eczema. In 57 
(62,0 %) patients with eczema, pathological process 
in the skin was widespread in nature, in 35 (38,0 %) 
it was limited. 29 (31,5 %) patients with eczema 
were diagnosed for the first time, it was acute or 
subacute, in 25 (27,2 %) of them it lasted from 1 to 3 
years and in 38 (41,3 %) – over 3 years. The control 
group involved 35 healthy individuals (donors) of 
the same age.  
In order to assess the state of nonspecific 
resistance of the organism in patients with eczema, 
we determined the phagocytosis indices – phagocytic 
activity (PA) and phagocytic number (PN) of 
polymorphonuclear leukocytes characterizing the 
initial stages of phagocytosis, spontaneous NBT test 
(test of nitro blue tetrazolium recovery), which 
reflects the degree of functional stimulation of 
phagocytic cells and their ability to phagocytosis and 
NBT-test which was stimulated with pirogenal, 
characterizing the potential activity of phagocytic 
cells and is seen as a test of their readiness to 
complete phagocytosis and complement titer (by 
known methods) [8].  
Statistical analysis of the results of research was 
carried out using the methods of statistical analysis 
[6] by means of  the computer program Statistica 6.0, 
as the the probable difference we took the average at 
p<0,05. 
Results and discussion. In determining phago-
cytosis indices in 92 patients with eczema, we estab-
lished their probable changes compared with those of 
the control group (the data are shown in the table). 
For example, a significant decrease in PA (by 3,7 %, 
p=0,029) was found in patients with eczema, which 
describes the initial stages of phagocytosis, as well 
as a significant decrease in spontaneous NBT-test 
(by 11,8 %, p=0,014) and stimulated NBT test (by 
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13,9 %, p=0,003), which represent the final stage of 
the process of phagocytosis.  
At the same time, examined patients with 
eczema had a significant, compared with that of 
control group, increase in titer of complement (by 
22,7 %, p=0,005), which is involved in the 
implementation of immune responses, activation of 
phagocytosis and increases penetrability of the 
vascular  walls ,  which are important 
pathophysiological and histopathological processes 
underlying the development of inflammatory 
manifestations in the skin of patients with eczema.  
An analysis of phagocytosis indices in patients 
with different clinical forms of eczema showed that 
patients suffering from microbial eczema, there is a 
significant, compared to the control group, reduction 
in PA (by 5,6 %, p<0,05) and a significant decrease 
of NST-test and stimulated NBT test (by 16,7 % and 
16,0 %, p<0,001respectively) for only downward 
trend of these parameters in patients with true 
eczema compared with those of the control group. 
A comparative analysis of phagocytosis in 
patients with different clinical forms of eczema re-
vealed significant differences – significant decline in 
phagocytic activity of polymorphonuclear leukocytes 
(by 4,3 %, p=0,014) in patients with microbial 
eczema compared with those having true eczema and 
a significant decrease of NBT-test indices (by 
12,8 %, p=0,022) and stimulated NBT test (by 
11,3 %, p=0,025), characterizing the final stages of 
the phagocytic process without significant 
differences in titer of complement index. 
At the same time, the comparative analysis of 
phagocytosis and complement indices in patients 
with eczema, depending on the area of skin lesions 
(limited or common forms of dermatosis) and the 
duration of dermatosis course (under 1 year, from1 
to 3 years, over 3 years) showed that there were no 
significant differences between the studied 
parameters in corresponding groups of patients. 
Thus, the analysis of nonspecific resistance in-
dices of the organism in patients with eczema, 
depending on the nature of the clinical course of 
dermatosis found unidirectional changes in rates of 
phagocytosis and complement levels in patients with 
different clinical forms of dermatosis. At the same 
time, we established a significant decrease of 
phagocytosis indices, characterizing the initial and 
final stages of the phagocytic process in patients with 
microbial eczema compared with patients who suffer 
from trueeczema without significant differences be-
tween the studied parameters depending on the 
prevalence and duration of the skin disease. 
The fact that it was the patients with microbial 
eczema who had a significant decrease in phagocytic 
activity of phagocytic blood cells involved in the 
capture and removal of microbial agents can serve as 
one of the key mechanisms, among other 
pathogenetic factors as to the development of 
chronic infection foci in the patient’s body with 
subsequent formation of microbial sensitization and 
microbial eczema in them. At the same time, an in-
crease of compliment titer  in patients with 
eczema,which is involved in immune mechanisms of 
inflammation and increases the penetration of the 
vascular wall, contributes to the strengthening of 
exudative manifestations and chronization of 
eczematous process in the skin of these patients. 
Conclusion 
Patients with eczema had significant changes in 
nonspecific resistance indices, which is indicative of 
a significant decrease in the phagocytic activity of 
phagocytic blood cells in patients with microbial 
eczema compared with true eczema without signifi-
cant differences between phagocytosis indices and 
complement rate, depending on the area of skin le-
sions and the duration of dermatosis course that 
should be considered when planning differentiated 
therapeutic tactics for these patients. 
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Notes. 1. р – degree of the significance of indices difference compared to the control group. 2. p1-2 – significance of indices 
difference between the patients with microbial and those with true eczemas 
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Prospects for further research. The prospects 
for further research lie in developing and evaluating 
the efficacy of the improved comprehensive treat-
ment method for patients with eczema, considering 
the evolution of indices of their body nonspecific 
resistance.  
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СОСТОЯНИЕ ПОКАЗАТЕЛЕЙ НЕСПЕЦИФИЧЕСКОЙ РЕЗИСТЕНТНОСТИ  
У БОЛЬНЫХ ЭКЗЕМОЙ С РАЗНЫМ КЛИНИЧЕСКИМ ТЕЧЕНИЕМ 
Н.А. Степан 
Резюме. Проведен анализ показателей неспецифической резистентности организма у больных экземой в зави-
симости от характера клинического течения дерматоза. Установлены однонаправленные изменения показателей 
фагоцитоза и уровня комплемента у больных экземой с различным ее клиническим течением при наличии более 
существенного уменьшения фагоцитарной активности фагоцитирующих клеток крови у больных микробной экзе-
мой по сравнению с истинной экземой без достоверных отличий показателей фагоцитоза в зависимости от площа-
ди поражения кожи и длительности течения дерматоза. 
Ключевые слова: экзема, клиническое течение, неспецифическая резистентность. 
СТАН ПОКАЗНИКІВ НЕСПЕЦИФІЧНОЇ РЕЗИСТЕНТНОСТІ У ХВОРИХ  
НА ЕКЗЕМУ З РІЗНИМ КЛІНІЧНИМ ПЕРЕБІГОМ 
Н.А. Степан 
Резюме. Проведено аналіз показників неспецифічної резистентності організму у хворих на екзему залежно від 
характеру клінічного перебігу дерматозу. Встановлено односпрямовані зміни показників фагоцитозу та рівня компле-
менту у хворих на екзему з різним її клінічним перебігом за наявності більш істотного зменшення фагоцитарної акти-
вності фагоцитувальних клітин крові у хворих на мікробні форми екземи порівняно з істинною екземою без вірогід-
них відмінностей показників фагоцитозу залежно від площі ураження шкіри та тривалості перебігу дерматозу. 
Ключові слова: екзема, клінічний перебіг, неспецифічна резистентність. 
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